Skip to main content
Top
Published in: Journal of Bone and Mineral Metabolism 1/2016

01-01-2016 | Original Article

Strong effect of SNP rs4988300 of the LRP5 gene on bone phenotype of Caucasian postmenopausal women

Authors: Péter Horváth, Bernadett Balla, János P. Kósa, Bálint Tóbiás, Balázs Szili, Gyöngyi Kirschner, Gabriella Győri, Karina Kató, Péter Lakatos, István Takács

Published in: Journal of Bone and Mineral Metabolism | Issue 1/2016

Login to get access

Abstract

The purpose of this study was to identify relationships between single nucleotide polymorphisms (SNPs) in the genes of the Wnt pathway and bone mineral density (BMD) of postmenopausal women. We chose this pathway due to its importance in bone metabolism that was underlined in several studies. DNA samples of 932 Hungarian postmenopausal women were studied. First, their BMD values at different sites (spine, total hip) were measured, using a Lunar Prodigy DXA scanner. Thereafter, T-score values and the patients’ body mass indices (BMIs) were calculated, while information about the fracture history of the sample population was also collected. We genotyped nine SNPs of the following three genes: LRP5, GPR177, and SP7, using a Sequenom MassARRAY Analyzer 4 instrument. The genomic DNA samples used for genotyping were extracted from the buccal mucosa of the subjects. Statistical analyses were carried out using the SPSS 21 and R package. The results of this analysis showed a significant association between SNP rs4988300 of the LRP5 gene and total hip BMD values. We could not reveal any associations between the markers of GPR177, SP7, and bone phenotypes. We found no effect of these genotypes on fracture risk. We could demonstrate a significant gene–gene interaction between two SNPs of LRP5 (rs4988300 and rs634008, p = 0.009) which was lost after Bonferroni correction. We could firmly demonstrate a significant association between rs4988300 of the LRP5 gene and bone density of the hip on the largest homogeneous postmenopausal study group analyzed to date. Our finding corroborates the relationship between LRP5 genotype and bone phenotype in postmenopausal women, however, the complete mechanism of this relationship requires further investigations.
Appendix
Available only for authorised users
Literature
2.
go back to reference Hsu YH, Kiel DP (2012) Clinical review: genome-wide association studies of skeletal phenotypes: what we have learned and where we are headed. J Clin Endocrinol Metab 97:E1958–E1977PubMedPubMedCentralCrossRef Hsu YH, Kiel DP (2012) Clinical review: genome-wide association studies of skeletal phenotypes: what we have learned and where we are headed. J Clin Endocrinol Metab 97:E1958–E1977PubMedPubMedCentralCrossRef
3.
go back to reference Paternoster L, Lorentzon M, Vandenput L et al (2010) Genome-wide association meta-analysis of cortical bone mineral density unravels allelic heterogeneity at the RANKL locus and potential pleiotropic effects on bone. PLoS Genet 6:e1001217PubMedPubMedCentralCrossRef Paternoster L, Lorentzon M, Vandenput L et al (2010) Genome-wide association meta-analysis of cortical bone mineral density unravels allelic heterogeneity at the RANKL locus and potential pleiotropic effects on bone. PLoS Genet 6:e1001217PubMedPubMedCentralCrossRef
4.
go back to reference Takacs I, Lazary A, Kosa JP et al (2010) Allelic variations of RANKL/OPG signaling system are related to bone mineral density and in vivo gene expression. Eur J Endocrinol 162:423–431PubMedCrossRef Takacs I, Lazary A, Kosa JP et al (2010) Allelic variations of RANKL/OPG signaling system are related to bone mineral density and in vivo gene expression. Eur J Endocrinol 162:423–431PubMedCrossRef
5.
go back to reference Lazary A, Kosa JP, Tobias B et al (2008) Single nucleotide polymorphisms in new candidate genes are associated with bone mineral density and fracture risk. Eur J Endocrinol 159:187–196PubMedCrossRef Lazary A, Kosa JP, Tobias B et al (2008) Single nucleotide polymorphisms in new candidate genes are associated with bone mineral density and fracture risk. Eur J Endocrinol 159:187–196PubMedCrossRef
6.
go back to reference Kumar J, Swanberg M, McGuigan F, Callreus M, Gerdhem P, Akesson K (2011) LRP4 association to bone properties and fracture and interaction with genes in the Wnt- and BMP signaling pathways. Bone 49:343–348PubMedCrossRef Kumar J, Swanberg M, McGuigan F, Callreus M, Gerdhem P, Akesson K (2011) LRP4 association to bone properties and fracture and interaction with genes in the Wnt- and BMP signaling pathways. Bone 49:343–348PubMedCrossRef
7.
go back to reference Li X, Grisanti M, Fan W et al (2011) Dickkopf-1 regulates bone formation in young growing rodents and upon traumatic injury. J Bone Miner Res 26:2610–2621PubMedCrossRef Li X, Grisanti M, Fan W et al (2011) Dickkopf-1 regulates bone formation in young growing rodents and upon traumatic injury. J Bone Miner Res 26:2610–2621PubMedCrossRef
8.
go back to reference Wend P, Wend K, Krum SA, Miranda-Carboni GA (2012) The role of WNT10B in physiology and disease. Acta Physiol (Oxf) 204:34–51CrossRef Wend P, Wend K, Krum SA, Miranda-Carboni GA (2012) The role of WNT10B in physiology and disease. Acta Physiol (Oxf) 204:34–51CrossRef
9.
go back to reference Baron R, Kneissel M (2013) WNT signaling in bone homeostasis and disease: from human mutations to treatments. Nat Med 19:179–192PubMedCrossRef Baron R, Kneissel M (2013) WNT signaling in bone homeostasis and disease: from human mutations to treatments. Nat Med 19:179–192PubMedCrossRef
10.
go back to reference Maeda K, Takahashi N, Kobayashi Y (2013) Roles of Wnt signals in bone resorption during physiological and pathological states. J Mol Med (Berl) 91:15–23CrossRef Maeda K, Takahashi N, Kobayashi Y (2013) Roles of Wnt signals in bone resorption during physiological and pathological states. J Mol Med (Berl) 91:15–23CrossRef
11.
go back to reference Regard JB, Zhong Z, Williams BO, Yang Y (2012) Wnt signaling in bone development and disease: making stronger bone with Wnts. Cold Spring Harb Perspect Biol 4:a007997PubMedPubMedCentralCrossRef Regard JB, Zhong Z, Williams BO, Yang Y (2012) Wnt signaling in bone development and disease: making stronger bone with Wnts. Cold Spring Harb Perspect Biol 4:a007997PubMedPubMedCentralCrossRef
12.
go back to reference Day TF, Guo X, Garrett-Beal L, Yang Y (2005) Wnt/β-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis. Dev Cell 8:739–750PubMedCrossRef Day TF, Guo X, Garrett-Beal L, Yang Y (2005) Wnt/β-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis. Dev Cell 8:739–750PubMedCrossRef
13.
go back to reference Gong Y, Slee RB, Fukai N et al (2001) LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell 107:513–523PubMedCrossRef Gong Y, Slee RB, Fukai N et al (2001) LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell 107:513–523PubMedCrossRef
14.
go back to reference He X, Semenov M, Tamai K, Zeng X (2004) LDL receptor-related proteins 5 and 6 in Wnt/β-catenin signaling: arrows point the way. Development 131:1663–1677PubMedCrossRef He X, Semenov M, Tamai K, Zeng X (2004) LDL receptor-related proteins 5 and 6 in Wnt/β-catenin signaling: arrows point the way. Development 131:1663–1677PubMedCrossRef
16.
go back to reference Ichikawa S, Koller DL, Padgett LR, Lai D, Hui SL, Peacock M, Foroud T, Econs MJ (2010) Replication of previous genome-wide association studies of bone mineral density in premenopausal American women. J Bone Miner Res 25:1821–1829PubMedPubMedCentralCrossRef Ichikawa S, Koller DL, Padgett LR, Lai D, Hui SL, Peacock M, Foroud T, Econs MJ (2010) Replication of previous genome-wide association studies of bone mineral density in premenopausal American women. J Bone Miner Res 25:1821–1829PubMedPubMedCentralCrossRef
17.
go back to reference Estrada K, Styrkarsdottir U, Evangelou E et al (2012) Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture. Nat Genet 44:491–501PubMedPubMedCentralCrossRef Estrada K, Styrkarsdottir U, Evangelou E et al (2012) Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture. Nat Genet 44:491–501PubMedPubMedCentralCrossRef
18.
go back to reference Bartscherer K, Pelte N, Ingelfinger D, Boutros M (2006) Secretion of Wnt ligands requires Evi, a conserved transmembrane protein. Cell 125:523–533PubMedCrossRef Bartscherer K, Pelte N, Ingelfinger D, Boutros M (2006) Secretion of Wnt ligands requires Evi, a conserved transmembrane protein. Cell 125:523–533PubMedCrossRef
19.
go back to reference Maruyama T, Jiang M, Hsu W (2013) Gpr177, a novel locus for bone mineral density and osteoporosis, regulates osteogenesis and chondrogenesis in skeletal development. J Bone Miner Res 28:1150–1159PubMedPubMedCentralCrossRef Maruyama T, Jiang M, Hsu W (2013) Gpr177, a novel locus for bone mineral density and osteoporosis, regulates osteogenesis and chondrogenesis in skeletal development. J Bone Miner Res 28:1150–1159PubMedPubMedCentralCrossRef
20.
go back to reference Rivadeneira F, Styrkársdottir U, Estrada K et al (2009) Twenty bone-mineral-density loci identified by large-scale meta-analysis of genome-wide association studies. Nat Genet 41:1199–1206PubMedPubMedCentralCrossRef Rivadeneira F, Styrkársdottir U, Estrada K et al (2009) Twenty bone-mineral-density loci identified by large-scale meta-analysis of genome-wide association studies. Nat Genet 41:1199–1206PubMedPubMedCentralCrossRef
21.
go back to reference Chen D, Li Y, Zhou Z, Xing Y, Zhong Y, Zou X, Tian W, Zhang C (2012) Synergistic inhibition of Wnt pathway by HIF-1alpha and osteoblast-specific transcription factor osterix (Osx) in osteoblasts. PLoS ONE 7:e52948PubMedPubMedCentralCrossRef Chen D, Li Y, Zhou Z, Xing Y, Zhong Y, Zou X, Tian W, Zhang C (2012) Synergistic inhibition of Wnt pathway by HIF-1alpha and osteoblast-specific transcription factor osterix (Osx) in osteoblasts. PLoS ONE 7:e52948PubMedPubMedCentralCrossRef
22.
go back to reference Kobayashi T, Kronenberg H (2005) Minireview: transcriptional regulation in development of bone. Endocrinology 146:1012–1017PubMedCrossRef Kobayashi T, Kronenberg H (2005) Minireview: transcriptional regulation in development of bone. Endocrinology 146:1012–1017PubMedCrossRef
23.
go back to reference Dalle Carbonare L, Valenti MT, Zanatta M, Donatelli L, Lo Cascio V (2009) Circulating mesenchymal stem cells with abnormal osteogenic differentiation in patients with osteoporosis. Arthritis Rheum 60:3356–3365PubMedCrossRef Dalle Carbonare L, Valenti MT, Zanatta M, Donatelli L, Lo Cascio V (2009) Circulating mesenchymal stem cells with abnormal osteogenic differentiation in patients with osteoporosis. Arthritis Rheum 60:3356–3365PubMedCrossRef
24.
go back to reference Gonzalez JR, Armengol L, Sole X, Guino E, Mercader JM, Estivill X, Moreno V (2007) SNPassoc: an R package to perform whole genome association studies. Bioinformatics 23:644–645PubMed Gonzalez JR, Armengol L, Sole X, Guino E, Mercader JM, Estivill X, Moreno V (2007) SNPassoc: an R package to perform whole genome association studies. Bioinformatics 23:644–645PubMed
25.
go back to reference Riancho JA, Olmos JM, Pineda B et al (2011) Wnt receptors, bone mass, and fractures: gene-wide association analysis of LRP5 and LRP6 polymorphisms with replication. Eur J Endocrinol 164:123–131PubMedCrossRef Riancho JA, Olmos JM, Pineda B et al (2011) Wnt receptors, bone mass, and fractures: gene-wide association analysis of LRP5 and LRP6 polymorphisms with replication. Eur J Endocrinol 164:123–131PubMedCrossRef
26.
go back to reference Tuysuz B, Bursali A, Alp Z, Suyugul N, Laine CM, Makitie O (2012) Osteoporosis-pseudoglioma syndrome: three novel mutations in the LRP5 gene and response to bisphosphonate treatment. Horm Res Paediatr 77:115–120PubMedCrossRef Tuysuz B, Bursali A, Alp Z, Suyugul N, Laine CM, Makitie O (2012) Osteoporosis-pseudoglioma syndrome: three novel mutations in the LRP5 gene and response to bisphosphonate treatment. Horm Res Paediatr 77:115–120PubMedCrossRef
27.
go back to reference Laine CM, Chung BD, Susic M et al (2011) Novel mutations affecting LRP5 splicing in patients with osteoporosis-pseudoglioma syndrome (OPPG). Eur J Hum Genet 19:875–881PubMedPubMedCentralCrossRef Laine CM, Chung BD, Susic M et al (2011) Novel mutations affecting LRP5 splicing in patients with osteoporosis-pseudoglioma syndrome (OPPG). Eur J Hum Genet 19:875–881PubMedPubMedCentralCrossRef
28.
go back to reference Boyden LM, Mao J, Belsky J et al (2002) High bone density due to a mutation in LDL-receptor-related protein 5. N Engl J Med 346:1513–1521PubMedCrossRef Boyden LM, Mao J, Belsky J et al (2002) High bone density due to a mutation in LDL-receptor-related protein 5. N Engl J Med 346:1513–1521PubMedCrossRef
29.
go back to reference Hill TP, Später D, Taketo MM, Birchmeier W, Hartmann C (2005) Canonical Wnt/β-catenin signaling prevents osteoblasts from differentiating into chondrocytes. Dev Cell 8:727–738PubMedCrossRef Hill TP, Später D, Taketo MM, Birchmeier W, Hartmann C (2005) Canonical Wnt/β-catenin signaling prevents osteoblasts from differentiating into chondrocytes. Dev Cell 8:727–738PubMedCrossRef
30.
go back to reference Hu H, Hilton MJ, Tu X, Yu K, Ornitz DM, Long F (2005) Sequential roles of Hedgehog and Wnt signaling in osteoblast development. Development 132:49–60PubMedCrossRef Hu H, Hilton MJ, Tu X, Yu K, Ornitz DM, Long F (2005) Sequential roles of Hedgehog and Wnt signaling in osteoblast development. Development 132:49–60PubMedCrossRef
31.
go back to reference Xiong DH, Shen H, Zhao LJ et al (2006) Robust and comprehensive analysis of 20 osteoporosis candidate genes by very high-density single-nucleotide polymorphism screen among 405 white nuclear families identified significant association and gene-gene interaction. J Bone Miner Res 21:1678–1695PubMedPubMedCentralCrossRef Xiong DH, Shen H, Zhao LJ et al (2006) Robust and comprehensive analysis of 20 osteoporosis candidate genes by very high-density single-nucleotide polymorphism screen among 405 white nuclear families identified significant association and gene-gene interaction. J Bone Miner Res 21:1678–1695PubMedPubMedCentralCrossRef
32.
go back to reference Kiel DP, Demissie S, Dupuis J, Lunetta KL, Murabito JM, Karasik D (2007) Genome-wide association with bone mass and geometry in the Framingham Heart Study. BMC Med Genet 8(Suppl 1):S14PubMedPubMedCentralCrossRef Kiel DP, Demissie S, Dupuis J, Lunetta KL, Murabito JM, Karasik D (2007) Genome-wide association with bone mass and geometry in the Framingham Heart Study. BMC Med Genet 8(Suppl 1):S14PubMedPubMedCentralCrossRef
33.
go back to reference Cefalu CA (2004) Is bone mineral density predictive of fracture risk reduction? Curr Med Res Opin 20:341–349PubMedCrossRef Cefalu CA (2004) Is bone mineral density predictive of fracture risk reduction? Curr Med Res Opin 20:341–349PubMedCrossRef
35.
go back to reference Jin J, Morse M, Frey C, Petko J, Levenson R (2010) Expression of GPR177 (Wntless/Evi/Sprinter), a highly conserved Wnt-transport protein, in rat tissues, zebrafish embryos, and cultured human cells. Dev Dyn 239:2426–2434PubMedPubMedCentralCrossRef Jin J, Morse M, Frey C, Petko J, Levenson R (2010) Expression of GPR177 (Wntless/Evi/Sprinter), a highly conserved Wnt-transport protein, in rat tissues, zebrafish embryos, and cultured human cells. Dev Dyn 239:2426–2434PubMedPubMedCentralCrossRef
36.
go back to reference Fu J, Jiang M, Mirando AJ, Yu HM, Hsu W (2009) Reciprocal regulation of Wnt and Gpr177/mouse Wntless is required for embryonic axis formation. Proc Natl Acad Sci USA 106:18598–18603PubMedPubMedCentralCrossRef Fu J, Jiang M, Mirando AJ, Yu HM, Hsu W (2009) Reciprocal regulation of Wnt and Gpr177/mouse Wntless is required for embryonic axis formation. Proc Natl Acad Sci USA 106:18598–18603PubMedPubMedCentralCrossRef
37.
go back to reference Roshandel D, Thomson W, Pye SR et al (2011) Polymorphisms in genes involved in the NF-kappaB signalling pathway are associated with bone mineral density, geometry and turnover in men. PLoS One 6:e28031PubMedPubMedCentralCrossRef Roshandel D, Thomson W, Pye SR et al (2011) Polymorphisms in genes involved in the NF-kappaB signalling pathway are associated with bone mineral density, geometry and turnover in men. PLoS One 6:e28031PubMedPubMedCentralCrossRef
38.
go back to reference Chauveau C, Broux O, Delecourt C, Hardouin P, Jeanfils J, Devedjian JC (2008) Gene expression in normotopic and heterotopic human bone: increased level of SP7 mRNA in pathological tissue. Mol Cell Biochem 318:81–87PubMedCrossRef Chauveau C, Broux O, Delecourt C, Hardouin P, Jeanfils J, Devedjian JC (2008) Gene expression in normotopic and heterotopic human bone: increased level of SP7 mRNA in pathological tissue. Mol Cell Biochem 318:81–87PubMedCrossRef
39.
go back to reference Mendez JP, Rojano-Mejia D, Coral-Vazquez RM et al (2013) Impact of genetic variants of IL-6, IL6R, LRP5, ESR1 and SP7 genes on bone mineral density in postmenopausal Mexican-Mestizo women with obesity. Gene 528:216–220PubMedCrossRef Mendez JP, Rojano-Mejia D, Coral-Vazquez RM et al (2013) Impact of genetic variants of IL-6, IL6R, LRP5, ESR1 and SP7 genes on bone mineral density in postmenopausal Mexican-Mestizo women with obesity. Gene 528:216–220PubMedCrossRef
Metadata
Title
Strong effect of SNP rs4988300 of the LRP5 gene on bone phenotype of Caucasian postmenopausal women
Authors
Péter Horváth
Bernadett Balla
János P. Kósa
Bálint Tóbiás
Balázs Szili
Gyöngyi Kirschner
Gabriella Győri
Karina Kató
Péter Lakatos
István Takács
Publication date
01-01-2016
Publisher
Springer Japan
Published in
Journal of Bone and Mineral Metabolism / Issue 1/2016
Print ISSN: 0914-8779
Electronic ISSN: 1435-5604
DOI
https://doi.org/10.1007/s00774-014-0645-z

Other articles of this Issue 1/2016

Journal of Bone and Mineral Metabolism 1/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.